Chazy, NY, United States of America

Robert P Waranis



Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 259(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Robert P Waranis

Introduction

Robert P Waranis is a notable inventor based in Chazy, NY (US), recognized for his contributions to pharmaceutical formulations. With a total of 5 patents, Waranis has made significant strides in the field of injectable and oral rapamycin solutions.

Latest Patents

Waranis's latest patents include a rapamycin formulation for IV injection, which discloses an aqueous, injectable rapamycin solution comprising 40 to 75 volume percent of a concentrate solution of rapamycin in propylene glycol. This formulation features rapamycin concentrations ranging from 0.25 mg/ml to 8 mg/ml, combined with a diluent solution of water, where the concentration of rapamycin in the combined solution ranges from 0.1 mg/ml to 4 mg/ml. Another significant patent is for rapamycin formulations for oral administration, which contains, per 100 ml of the formulation, from about 0.01 to about 10.0 grams of rapamycin, along with surfactants and lecithin or phospholipid solutions.

Career Highlights

Waranis has been associated with American Home Products Corporation, where he has contributed to the development of innovative pharmaceutical solutions. His work has been instrumental in advancing the delivery methods of rapamycin, a compound with various therapeutic applications.

Collaborations

Throughout his career, Waranis has collaborated with notable colleagues, including Thomas W Leonard and Maureen M Harrison, enhancing the scope and impact of his inventions.

Conclusion

Robert P Waranis stands out as a significant figure in the field of pharmaceutical innovation, with his patents paving the way for improved formulations of rapamycin. His contributions continue to influence the industry and enhance therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…